Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Drugs in Development News & Deals for NCGC00024357-07

    Client Email Product

    NCGC00024357-07

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    13
    US DMFs Filed

    US DMFs Filed

    6
    CEP/COS Certifications

    CEP/COS Certifications

    3
    JDMFs Filed

    JDMFs Filed

    2
    Other Certificates

    Other Certificates

    4
    Other Suppliers

    Other Suppliers

    8
    API REF. PRICE (USD / KG)
    7,355

    API Market Place

    5
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    0

    Europe

    Europe

    2
    Canada

    Canada

    2
    Australia

    Australia

    0

    South Africa

    South Africa

    2
    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS
    136
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    2
    REF STANDARD

    EDQM

    2

    USP

    1

    JP

    11

    Other Listed Suppliers

    2
    SERVICES

    0

    Full View ScreenFull Screen View
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Defender Pharmaceuticals Receives Complete Response Letter from the U.S. Food and Drug Administration for its Intranasal Scopolamine (DPI-386) New Drug ...

    Details:

    DPI-386 (scopolamine hydrobromide) is a mAChRs inhibitor which is being evaluated in phase 3 clinical trials for the treatment of motion sickness in adults.


    Lead Product(s): Scopolamine Hydrobromide

    Therapeutic Area: Neurology Product Name: DPI-386

    Highest Development Status: Phase IIIProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable January 30, 2024

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Defender Pharmaceuticals Announces Collaboration with NASA on Two Phase 2 Clinical Trials Investigating DPI-386™s Ability to Mitigate G-transition Ind...

    Details:

    DPI-386 (scopolamine hydrobromide) intranasal gel, which is in late-stage development for the prevention of nausea and vomiting induced by motion sickness.


    Lead Product(s): Scopolamine Hydrobromide

    Therapeutic Area: Neurology Product Name: DPI-386

    Highest Development Status: Phase IIIProduct Type: Small molecule

    Partner/Sponsor/Collaborator: National Aeronautics and Space Administration

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable October 24, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    FDA Accepts Defender Pharmaceuticals™ New Drug Application for Intranasal Scopolamine Gel

    Details:

    DPI-386 (scopolamine hydrobromide) intranasal gel, which is in late-stage development for the prevention of nausea and vomiting induced by motion sickness.


    Lead Product(s): Scopolamine Hydrobromide

    Therapeutic Area: Neurology Product Name: DPI-386

    Highest Development Status: Phase IIIProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable September 26, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Defender Pharmaceuticals Announces Submission of New Drug Application to FDA with Intranasal Scopolamine for Prevention of Nausea and Vomiting Induced b...

    Details:

    DPI-386 (scopolamine hydrobromide) intranasal gel, which is in late-stage development for the prevention of nausea and vomiting induced by motion sickness.


    Lead Product(s): Scopolamine Hydrobromide

    Therapeutic Area: Neurology Product Name: DPI-386

    Highest Development Status: Phase IIIProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable July 26, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Defender Pharmaceuticals Reports Positive Results from Pivotal Phase III Clinical Trial of Intranasal Scopolamine for the Prevention of Nausea and Vomit...

    Details:

    DPI-386 (scopolamine hydrobromide) Intranasal gel, which is in late-stage development for the prevention of nausea and vomiting induced by motion sickness.


    Lead Product(s): Scopolamine Hydrobromide

    Therapeutic Area: Neurology Product Name: DPI-386

    Highest Development Status: Phase IIIProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable June 05, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Alchem Hyoscine Scopolamine Hydrobromide

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Transo Pharm Handels GmbH

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search